www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehenhttp://www.finanzen.netde-deSmartHouse Media GmbHhttp://finanzen.net/images/finanzen_net.gifhttp://www.finanzen.nethttp://www.finanzen.net/nachricht/Wellcome_Trust_Case_Control_Consortium_and_Affymetrix_Expand_World_s_Largest_Study_of_Genetic_Diseases_758484Affymetrix, Inc. (Nasdaq:AFFX) today announced that the Wellcome Trust of Great Britain has awarded to Affymetrix the second phase of its Case Control Consortium (WTCCC) project, the world’s largest-ever study of the genetics behind ...http://www.finanzen.net/nachricht/Wellcome_Trust_Case_Control_Consortium_and_Affymetrix_Expand_World_s_Largest_Study_of_Genetic_Diseases_758484http://www.finanzen.net/nachricht/Affymetrix_Reports_Second_Quarter_2008_Results_758456Affymetrix Inc., (Nasdaq:AFFX) today reported its operating results for the second quarter of 2008. Total revenue for the quarter was $86.9 million, as compared to total revenue of $88.3 million in the second quarter of 2007. ...http://www.finanzen.net/nachricht/Affymetrix_Reports_Second_Quarter_2008_Results_758456http://www.finanzen.net/nachricht/Affymetrix_to_Host_Conference_Call_on_July_24_2008_to_Announce_Second_Quarter_2008_Results_751746Affymetrix, Inc. (Nasdaq:AFFX) today announced that it will release results for the second quarter 2008 after close of the stock market on Thursday, July 24, 2008. Affymetrix' management team will host a conference call on July ...http://www.finanzen.net/nachricht/Affymetrix_to_Host_Conference_Call_on_July_24_2008_to_Announce_Second_Quarter_2008_Results_751746http://www.finanzen.net/nachricht/Affymetrix_Technology_Used_to_Discover_Molecular_Mechanisms_of_Liver_Disease_747568Affymetrix Inc. (Nasdaq:AFFX) today announced that a team of researchers at the Fraunhofer Institute in Germany is using Affymetrix’ Whole Transcript (WT) gene expression technology to better understand the molecular basis of drug-induced ...http://www.finanzen.net/nachricht/Affymetrix_Technology_Used_to_Discover_Molecular_Mechanisms_of_Liver_Disease_747568http://www.finanzen.net/nachricht/Center_for_Inherited_Disease_Research_Adds_Affymetrix_Platform_for_Large_Scale_Genotyping_Services_741443Affymetrix Inc. (Nasdaq:AFFX) today announced that the Center for Inherited Disease Research (CIDR) has adopted its Genome-Wide Human SNP Array 6.0 for large-scale genotyping and copy number projects. CIDR is making Affymetrix-based ...http://www.finanzen.net/nachricht/Center_for_Inherited_Disease_Research_Adds_Affymetrix_Platform_for_Large_Scale_Genotyping_Services_741443http://www.finanzen.net/nachricht/Case_Western_Reserve_University_and_TGen_Select_Affymetrix_SNP_Array_6_0_for_Diabetes_Study_738437Affymetrix Inc. (Nasdaq:AFFX) today announced that Case Western Reserve University and the Translational Genomics Research Institute (TGen) will use the Affymetrix Genome-Wide Human SNP Array 6.0 to discover genetic pathways associated ...http://www.finanzen.net/nachricht/Case_Western_Reserve_University_and_TGen_Select_Affymetrix_SNP_Array_6_0_for_Diabetes_Study_738437http://www.finanzen.net/nachricht/Affymetrix_Technology_Powers_First_Genomic_Tumor_Grading_Test_for_Breast_Cancer_734030Affymetrix Inc. (Nasdaq: AFFX) today announced that its technology powers the Ipsogen MapQuant Dx™ Genomic Grade, the first genomic test designed to provide a more precise measurement of tumor grade than previous techniques. Ipsogen, ...http://www.finanzen.net/nachricht/Affymetrix_Technology_Powers_First_Genomic_Tumor_Grading_Test_for_Breast_Cancer_734030http://www.finanzen.net/nachricht/Affymetrix_Applauds_Congress_and_President_for_Enacting_the_Genetic_Information_Nondiscrimination_Act_729841Affymetrix Inc. (Nasdaq:AFFX) applauds the U.S. Congress and President George W. Bush for enacting the Genetic Information Nondiscrimination Act (GINA). GINA establishes a much-needed federal prohibition in the United States against ...http://www.finanzen.net/nachricht/Affymetrix_Applauds_Congress_and_President_for_Enacting_the_Genetic_Information_Nondiscrimination_Act_729841http://www.finanzen.net/nachricht/Korea_NIH_Expands_KARE_Project_with_Second_Affymetrix_Technology_Order_727717Affymetrix Inc. (Nasdaq:AFFX) today announced that the Republic of Korea’s National Institute of Health (NIH) and Center for Disease Control and Prevention is expanding the Korean Association Resource (KARE) project and using the ...http://www.finanzen.net/nachricht/Korea_NIH_Expands_KARE_Project_with_Second_Affymetrix_Technology_Order_727717http://www.finanzen.net/nachricht/LineaGen_Selects_Affymetrix_Technology_to_Discover_Genes_Associated_With_Autism_and_Multiple_Sclerosis_723350Affymetrix Inc. (Nasdaq:AFFX) and LineaGen Inc. today announced that a team of prominent researchers at the University of Utah and Vanderbilt University are leveraging Utah’s deep domain expertise in human genetic research and the ...http://www.finanzen.net/nachricht/LineaGen_Selects_Affymetrix_Technology_to_Discover_Genes_Associated_With_Autism_and_Multiple_Sclerosis_723350